The NP/PA is a clinician who demonstrates clinical expertise and leadership skills. The NP/PA uses clinical and academic skills in the evaluation, diagnosis and treatment of patients with cancer or hematologic disorders.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
In collaboration with a physician, the NP/PA manages therapeutic regimens for acute and chronic problems associated with such disease, treatment and/or conditions. The NP/PA provides anticipatory guidance, patient and family education, and psychological and emotional support. The NP/PA has prescriptive authority which includes schedule II through V controlled substances in the Commonwealth of Massachusetts.
The NP/PA is a member of an interdisciplinary care team that requires effective communication and collaboration with co-workers at the Institute in addition to collaborating institutions and agencies. The role requires critical thinking, an understanding of research principles and practices and leadership that improves the quality of care and advances nursing/medical care within the work setting and throughout the community. The NP/PA takes advantage of formal and informal learning opportunities to strengthen his or her knowledge base in support of the Institute's Mission, Vision and Core Values.
The iTox Program is comprised of a multi-disciplinary staff, facilitating the inpatient and outpatient diagnosis and management of complex immontherapy associated toxicities. The iTox NP/PA will work in both the inpatient and ambulatory settings assessing and caring for patients, developing processes for streamlined care, and establishing workflows for triage, consults, and programmatic-wide initiatives.
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is honored to be one of the organizations to receive the American Academy of PAs’ (AAPA) Center for Healthcare Leadership and Management (CHLM) 2020-2021 Employer of Excellence Award. The EOE Awards, the first and only PA-specific award program for organizations, is designed to showcase employers that have implemented practices that create positive work environments for PAs and encourage collaborative provider teams.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.